APA

Mastrandrea L. D., Witten L., Carlsson Petri K. C., Hale P. M., Hedman H. K. & Riesenberg R. A. (20190603). Liraglutide effects in a paediatric (7-11 y) population with obesity: A randomized, double-blind, placebo-controlled, short-term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics. : Pediatric obesity.

Chicago

Mastrandrea Lucy D, Witten Louise, Carlsson Petri Kristin C, Hale Paula M, Hedman Hanna K and Riesenberg Robert A. 20190603. Liraglutide effects in a paediatric (7-11 y) population with obesity: A randomized, double-blind, placebo-controlled, short-term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics. : Pediatric obesity.

Harvard

Mastrandrea L. D., Witten L., Carlsson Petri K. C., Hale P. M., Hedman H. K. and Riesenberg R. A. (20190603). Liraglutide effects in a paediatric (7-11 y) population with obesity: A randomized, double-blind, placebo-controlled, short-term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics. : Pediatric obesity.

MLA

Mastrandrea Lucy D, Witten Louise, Carlsson Petri Kristin C, Hale Paula M, Hedman Hanna K and Riesenberg Robert A. Liraglutide effects in a paediatric (7-11 y) population with obesity: A randomized, double-blind, placebo-controlled, short-term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics. : Pediatric obesity. 20190603.